Results 211 to 220 of about 5,058,773 (393)
Supplementary Table from A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma
, 2023 Phillip M. Rappold, Lynda Vuong, Josef Leibold, Nicholas H. Chakiryan, Michael Curry, Fengshen Kuo, Erich Sabio, Hui Jiang, Briana G. Nixon, Ming Liu, Anders Berglund, Andrew W. Silagy, Eduardo A. Mascareno, Mahdi Golkaram, Mahtab Marker, Albert Reising, Alexander Savchenko, John M. Millholland, Ying‐Bei Chen, Paul Russo, Jonathan Coleman, Ed Reznik, Brandon J. Manley, Irina Ostrovnaya, Vladimir Makarov, Renzo G. DiNatale, Kyle A. Blum, Xiaoxiao Ma, Diego Chowell, Ming O. Li, David B. Solit, Scott W. Lowe, Timothy A. Chan, Robert J. Motzer, Martin H. Voss, A. Ari Hakimi +35 moreopenalex +1 more sourceAccumulation of99mTc-HM-PAO in photon deficient areas in bone scan of bone metastasis from hepatocellular carcinoma
, 1992 Nobuaki Otsuka, Masao Fukunaga, Koichi Morita, Shimato Ono, Kiyohisa Nagai, T Tomomitsu, Shinichi Yanagimoto, Hiroaki Mimura, Shinichiro Yamamoto, Yutaka Hirano +9 moreopenalex +1 more sourceRelato de caso: carcinoma diferenciado de tireoide de baixo risco sob perspectiva cirurgia ou vigilância ativa
, 2023 Carlos Alberto Menezes, Rayzza Santos Vasconcelos, Gabriele Soares Martins, Beatriz Gomes dos Santos, Itamara de Santana Lima, Felipe Martins Costa, Jociele Sales de Souza, Isabelle Oliveira Santos da Silva, Maria Eduarda Freire dos Santos, Roanne Yasmin Gonçalves Vasconcelos, Gabriele Paiva Santos, Rhaissa Giovana de Sousa, Giovana Bernardes, Genivaldo Galindo Neto, Arthur Brito-Marcelino +14 moreopenalex +2 more sourcesTemsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.
New England Journal of Medicine, 2007 G. Hudes, M. Carducci, P. Tomczak, J. Dutcher, R. Figlin, A. Kapoor, E. Starosławska, J. Sosman, D. McDermott, I. Bodrogi, Z. Kovačević, V. Lesovoy, I. Schmidt-Wolf, O. Barbarash, E. Gokmen, T. O'Toole, S. Lustgarten, L. Moore, R. Motzer +18 moresemanticscholar +1 more sourceTumor‐stromal crosstalk and macrophage enrichment are associated with chemotherapy response in bladder cancer
FEBS Open Bio, EarlyView.Chemoresistance in bladder cancer: Macrophage recruitment associated with CXCL1, CXCL5 and CXCL8 expression is characteristic of Gemcitabine/Cisplatin (Gem/Cis) Non‐Responder tumors (right side) while Responder tumors did not show substantial tumor‐stromal crosstalk (left side). All biological icons are attributed to Bioicons: carcinoma, cancerous‐cell‐Sophie Leypold, Janik Riese, Lancelot Seillier, Mark Kühnel, Julia Pannhausen, Charlotte O. J. Fröhlich, Christian Martin, Peter Boor, Matthias Saar, Danny D. Jonigk, Nadine T. Gaisa, Michael Rose +11 morewiley +1 more sourceClinical Characteristics and Outcomes of Early‐Onset Versus Late‐Onset LGI1‐Antibody Encephalitis
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background
Leucine‐rich glioma‐inactivated 1 antibody (LGI1‐Ab) encephalitis predominantly affected older individuals, but has also been reported in younger patients. However, the demographic, clinical, and prognostic characteristics of early‐onset LGI1‐Ab encephalitis have yet to be systematically elucidated. This study aims to systematically Yu Kong, Shasha Yu, Jing Zhang, Yu Zu, Yujing Zhang, Jing Lv, Xuyang Cao, Xuedan Feng +7 morewiley +1 more sourcePrimary Uterine NUT Carcinoma: A Case Report and Literature Review. [PDF]
Clin PractShiraishi T, Kisu I, Kaneko N, Fukuda T, Watanabe J, Hayashi R, Ueno A, Emoto K, Nakamura K, Nogami Y, Tsuji K, Masuda K, Yamagami W. +12 moreeuropepmc +1 more source